NEW YORK (GenomeWeb News) – MDxHealth today reported a 24 percent drop in revenues for its fourth quarter.

For the three months ended Dec. 31, 2013, the company said revenues fell to $1.6 million, compared to $2.1 million in the year-ago period, as PharmacoMDx revenues decreased due to the timing of the completion of projects, and focus shifted to ClinicalMDx opportunities, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.